Gudernova Iva, Foldynova-Trantirkova Silvie, Ghannamova Barbora El, Fafilek Bohumil, Varecha Miroslav, Balek Lukas, Hruba Eva, Jonatova Lucie, Jelinkova Iva, Kunova Bosakova Michaela, Trantirek Lukas, Mayer Jiri, Krejci Pavel
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Elife. 2017 Feb 15;6:e21536. doi: 10.7554/eLife.21536.
In-cell profiling enables the evaluation of receptor tyrosine activity in a complex environment of regulatory networks that affect signal initiation, propagation and feedback. We used FGF-receptor signaling to identify as a locus that strongly responds to the activation of a majority of the recognized protein kinase oncogenes, including 30 receptor tyrosine kinases and 154 of their disease-associated mutants. The promoter was engineered to enhance -activation capacity and optimized for simple screening assays with luciferase or fluorescent reporters. The efficacy of the developed, fully synthetic reporters was demonstrated by the identification of novel targets for two clinically used tyrosine kinase inhibitors, nilotinib and osimertinib. A universal reporter system for in-cell protein kinase profiling will facilitate repurposing of existing anti-cancer drugs and identification of novel inhibitors in high-throughput screening studies.
细胞内分析能够在影响信号起始、传播和反馈的复杂调控网络环境中评估受体酪氨酸活性。我们利用成纤维细胞生长因子(FGF)受体信号传导来鉴定一个位点,该位点对大多数已识别的蛋白激酶癌基因的激活有强烈反应,包括30种受体酪氨酸激酶及其154种与疾病相关的突变体。对该位点的启动子进行了工程改造,以增强其激活能力,并针对使用荧光素酶或荧光报告基因的简单筛选测定进行了优化。通过鉴定两种临床使用的酪氨酸激酶抑制剂尼洛替尼和奥希替尼的新靶点,证明了所开发的完全合成报告基因的有效性。用于细胞内蛋白激酶分析的通用报告系统将有助于现有抗癌药物的重新利用,并在高通量筛选研究中鉴定新型抑制剂。